<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Front Public Health</journal-id><journal-id journal-id-type="publisher-id">Front. Public Health</journal-id><journal-title-group><journal-title>Frontiers in Public Health</journal-title></journal-title-group><issn pub-type="epub">2296-2565</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013033</article-id><article-id pub-id-type="pmc">PMC11861555</article-id><article-id pub-id-type="doi">10.3389/fpubh.2025.1522790</article-id><article-categories><subj-group subj-group-type="heading"><subject>Public Health</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Trend of skin cancer mortality and years of life lost in China from 2013 to 2021</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jingyi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn0002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2753740/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Jiaqi</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn0002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1484891/overview"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Yuanchao</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c002" ref-type="corresp">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Huang</surname><given-names>Biran</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Dermatology, Huizhou First Hospital</institution>, <addr-line>Huizhou</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Dermatology, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University)</institution>, <addr-line>Zhuhai</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0004"><p>Edited by: Ravi Prakash Sahu, Wright State University, United States</p></fn><fn fn-type="edited-by" id="fn0005"><p>Reviewed by: Chao Yang, Southern Medical University, China</p><p>Xueting Zheng, Zhuhai Center for Disease Control and Prevention, China</p></fn><corresp id="c001">*Correspondence: Biran Huang, <email>hbr0200@163.com</email></corresp><corresp id="c002">Yuanchao Yang, <email>29838592@qq.com</email></corresp><fn fn-type="other" id="fn0002"><p><sup>&#x02020;</sup>ORCID: Jingyi Li, <ext-link xlink:href="https://orcid.org/0000-0001-9968-9933" ext-link-type="uri">orcid.org/0000-0001-9968-9933</ext-link></p><p>Jiaqi Zeng, <ext-link xlink:href="https://orcid.org/0000-0002-3192-8536" ext-link-type="uri">orcid.org/0000-0002-3192-8536</ext-link></p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>1522790</elocation-id><history><date date-type="received"><day>05</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Li, Zeng, Yang and Huang.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Li, Zeng, Yang and Huang</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec id="sec1"><title>Background</title><p>The mortality rates of skin cancer in Chinese population are increasing. However, research on skin cancer trends in China is limited. This study aimed to estimate the mortality trends of skin cancer in China within 2013&#x02013;2021.</p></sec><sec id="sec2"><title>Methods</title><p>A retrospective analysis of skin cancer deaths within 2013&#x02013;2021 was performed using the China death cause surveillance dataset compiled by the National Health Commission Statistics Information Center and the China Center for Disease Control and Prevention Chronic Non-Communicable Diseases Prevention and Control Center. The mortality rates of skin cancer were stratified by gender, age group, and area (urban or rural).</p></sec><sec id="sec3"><title>Results</title><p>From 2013 to 2021 in China, the crude mortality rate (CMR) of skin cancer increased, and the age-standardized mortality rate (ASMR), and age-standardized years of life lost (YLL) rate decreased. The ASMR and age-standardized YLL rate were 0.85/100,000 and 18.95/100,000 in 2013, respectively, and decreased to 0.75/100,000 and 16.84/100,000, respectively, in 2021. From 2013 to 2021, the CMR, ASMR, and age-standardized YLL rate of skin cancer were higher in males than in females and higher in rural areas rather than in urban ones. In terms of the highest age-specific mortality rate, it appeared in the age group of over 85&#x0202f;years old.</p></sec><sec id="sec4"><title>Conclusion</title><p>The burden of skin cancer remained heavily from 2013 to 2021 in China. Especially males, older adult, and rural residents had higher mortality. Thus, effective measures and strategies should be taken to reduce the incidence and mortality of skin cancer.</p></sec></abstract><kwd-group><kwd>China</kwd><kwd>disease burden</kwd><kwd>skin cancer</kwd><kwd>mortality rate</kwd><kwd>years of life lost</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="2"/><equation-count count="0"/><ref-count count="25"/><page-count count="7"/><word-count count="4171"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Aging and Public Health</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><title>Introduction</title><p>Skin cancer is one of the most common carcinomas worldwide, affecting all races and socioeconomic groups in all geographic areas (<xref rid="ref1" ref-type="bibr">1</xref>). Based on cellular origin, these diseases are primarily categorized as melanoma (MM) and non-melanoma skin cancer (NMSC), and NMSC is divided into basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) as the major histologic subtypes (<xref rid="ref2" ref-type="bibr">2</xref>). Skin cancer incidence is rising worldwide, covering all age groups especially middle-aged and older adult people. According to the International Agency for Research on Cancer, 1.518 million skin cancer new cases were diagnosed, with 121,000 new deaths worldwide in 2020 (<xref rid="ref3" ref-type="bibr">3</xref>). According to Skin Cancer Foundation Statistics, one in every three cancers diagnosed is skin cancer (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref5" ref-type="bibr">5</xref>). Skin cancer burdens vary widely across countries, and higher numbers, incidences, and mortality of skin cancer are observed in high sociodemographic index regions (<xref rid="ref1" ref-type="bibr">1</xref>). New Zealand and Australia have the highest incidence rates of MM in the world (50 and 48 cases per 100,000 persons, respectively), followed by the USA and Europe (<xref rid="ref6" ref-type="bibr">6</xref>). In terms of BCC, Australia, Europe, and USA have the highest incidence rates (<xref rid="ref6" ref-type="bibr">6</xref>). The incidence of skin cancer in China is lower than that in European countries and America. However, the incidence of MM has increased over the past two decades in China, reaching 0.62 per 100,000 in 2022 as estimated, and the mortality rate was 0.38 per 100,000 (<xref rid="ref7" ref-type="bibr">7</xref>). The incidence and burden of skin cancer are associated with demographic trends, socioeconomic development, race, and risk exposures (<xref rid="ref1" ref-type="bibr">1</xref>). Exposure to ultraviolet radiation (UVR) is the most well-established risk factor for skin cancer (<xref rid="ref5" ref-type="bibr">5</xref>).</p><p>Mortality rates have been used to characterize people&#x02019;s health status, however, those measures do not fully account for the burden of premature mortality (<xref rid="ref8" ref-type="bibr">8</xref>). Compared with mortality, years of life lost (YLL) is an important and common disease burden indicator, which takes the death count and life expectancy at death into consideration (<xref rid="ref9" ref-type="bibr">9</xref>). At present, researchers primarily focus on other cancers in China. Although the incidence and mortality of MM in China have been studied (<xref rid="ref10" ref-type="bibr">10</xref>, <xref rid="ref11" ref-type="bibr">11</xref>), publications on the burden of skin cancer are few. Accordingly, the current work aimed to assess the disease burden of skin cancer in China and to provide policy recommendations regarding interventions for reducing the burden of skin cancer.</p></sec><sec sec-type="materials|methods" id="sec6"><title>Materials and methods</title><sec id="sec7"><title>Data sources</title><p>Skin cancer mortality data in our study were obtained from the China death cause surveillance dataset<xref rid="fn0001" ref-type="fn"><sup>1</sup></xref> for the period of 2013&#x02013;2021. These data were acquired from the national mortality surveillance system with 605 surveillance points across China and about 24% of the Chinese population covered. They were compiled by the National Health Commission Statistics Information Center and the China Center for Disease Control and Prevention Chronic Non-Communicable Diseases Prevention and Control Center. Skin cancer mortality and the number of deaths were calculated by gender, age groups, and areas (urban or rural). Cause-specific mortality and deaths data for skin cancer were collected under strict quality-control measures with good national and provincial representation. We used the China&#x02019;s seventh census in 2020 as the standard population to estimate the age-standardized rate, which were obtained from the China National Bureau of Statistics.</p></sec><sec id="sec8"><title>Years of life lost estimation</title><p>YLL is a measure of premature death. It is calculated as the sum of each death multiplied by the standard life expectancy at each age. That is <italic>YLL (c, s, a, t)</italic>&#x0202f;=&#x0202f;<italic>N (c, s, a, t) &#x000d7; L (s, a)</italic> where: <italic>c</italic>, cause; <italic>a</italic>, age; <italic>s</italic>, sex and <italic>t</italic>, year; <italic>N (c, s, a, t)</italic> is the number of deaths due to the cause for the given age and sex in year; <italic>L (s, a)</italic> is a standard loss function specifying years of life lost for a death at age for sex (<xref rid="ref11" ref-type="bibr">11</xref>). We used a theoretical minimal risk reference life table to calculate YLL of skin cancer from 2013 to 2021.</p></sec><sec id="sec9"><title>Statistical analysis</title><p>The number of deaths, crude mortality rate (CMR), YLL, age-standardized mortality rate (ASMR), and age-standardized YLL rate caused by skin cancer from 2013 to 2021 were analyzed by sex, age groups, and areas (urban and rural). All statistical analyses were performed using SPSS 20.0 (<italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.05 indicates statistical significance) and graphed with Origin 2021.</p></sec></sec><sec sec-type="results" id="sec10"><title>Results</title><sec id="sec11"><title>Mortality rate and disease burden of skin cancer</title><p>From 2013 to 2021, skin cancer accounted for 17,261 deaths (9,495 males, 7,766 females) and 397421.34 YLL (227974.64 males and 169446.68 females) in China. The overall CMR of skin cancer, which tended to increase in the national surveillance areas, was between 0.69/100000 and 0.80/100000 from 2013 to 2021 (trend chi-square value&#x0202f;=&#x0202f;33.06, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01). Between 2013 and 2021, the ASMR of skin cancer decreased from 0.85/100,000 to 0.75/100,000 (trend chi-square value&#x0202f;=&#x0202f;150.85, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01). The age-standardized YLL rate of skin cancer showed similar trend to the ASMR from 2013 to 2021 and decreased from 18.95/100,000 to 16.84/100,000 (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>Trends in mortality rate, age-standardized mortality rate <bold>(A)</bold>, age-standardized YLL rate and YLL <bold>(B)</bold> of skin cancer in China, 2013&#x02013;2021.</p></caption><graphic xlink:href="fpubh-13-1522790-g001" position="float"/></fig></sec><sec id="sec12"><title>Age- and sex-specific mortality rates and disease burden of skin cancer</title><p>The CMR of skin cancer generally increased with age from 2013 to 2021. It increased from 45&#x0202f;years old and peaked at aged over 85&#x0202f;years. YLL rate showed similar trend to the CMR. We analyzed the age-specific mortality rates of skin cancer for different years. Compared with 2013, the CMR of skin cancer in most age groups decreased in 2021 in male, female, both sexes, and rural and urban areas (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="fig2"><label>Figure 2</label><caption><p>Age-specific mortality rates and YLL rate of skin cancer in whole population <bold>(A,B)</bold>, age-specific mortality rates by sex <bold>(C,D)</bold> and region <bold>(E,F)</bold> for skin cancers in China in 2013 and 2021.</p></caption><graphic xlink:href="fpubh-13-1522790-g002" position="float"/></fig><p>In terms of sex, the CMR, ASMR, and age-standardized YLL rate of males were consistently higher than that of females from 2013 to 2021 (<italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01). In males and females, the CMR of skin cancer tended to increase (trend chi-square value&#x0202f;=&#x0202f;9.64 and 26.60, respectively, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01), and the ASMR decreased (trend chi-square value&#x0202f;=&#x0202f;125.91 and 31.76, respectively, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01). Compared with 2013, the ASMR of skin cancer for males and females decreased by 12.88 and 11.59% respectively, and the age-standardized YLL rate for males and females decreased by 11.11 and 10.71%, respectively, in 2021 in China (<xref rid="tab1" ref-type="table">Table 1</xref>; <xref rid="fig3" ref-type="fig">Figure 3</xref>).</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>The sex-specific mortality rate, age-standardized mortality rate, and disease burden of skin cancer from 2013 to 2021.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Year</th><th align="center" valign="top" colspan="5" rowspan="1">Male</th><th align="center" valign="top" colspan="5" rowspan="1">Female</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Death numbers</th><th align="center" valign="top" rowspan="1" colspan="1">CMR</th><th align="center" valign="top" rowspan="1" colspan="1">ASMR</th><th align="center" valign="top" rowspan="1" colspan="1">YLL</th><th align="center" valign="top" rowspan="1" colspan="1">Age-standardized YLL rate</th><th align="center" valign="top" rowspan="1" colspan="1">Death numbers</th><th align="center" valign="top" rowspan="1" colspan="1">CMR</th><th align="center" valign="top" rowspan="1" colspan="1">ASMR</th><th align="center" valign="top" rowspan="1" colspan="1">YLL</th><th align="center" valign="top" rowspan="1" colspan="1">Age-standardized YLL rate</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">2013</td><td align="center" valign="top" rowspan="1" colspan="1">868</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td><td align="center" valign="top" rowspan="1" colspan="1">21375.48</td><td align="center" valign="top" rowspan="1" colspan="1">21.22</td><td align="center" valign="top" rowspan="1" colspan="1">693</td><td align="center" valign="top" rowspan="1" colspan="1">0.62</td><td align="center" valign="top" rowspan="1" colspan="1">0.78</td><td align="center" valign="top" rowspan="1" colspan="1">15926.17</td><td align="center" valign="top" rowspan="1" colspan="1">16.55</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2014</td><td align="center" valign="top" rowspan="1" colspan="1">951</td><td align="center" valign="top" rowspan="1" colspan="1">0.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.87</td><td align="center" valign="top" rowspan="1" colspan="1">23586.65</td><td align="center" valign="top" rowspan="1" colspan="1">20.38</td><td align="center" valign="top" rowspan="1" colspan="1">796</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td><td align="center" valign="top" rowspan="1" colspan="1">0.78</td><td align="center" valign="top" rowspan="1" colspan="1">17981.97</td><td align="center" valign="top" rowspan="1" colspan="1">16.30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">1,056</td><td align="center" valign="top" rowspan="1" colspan="1">0.81</td><td align="center" valign="top" rowspan="1" colspan="1">0.97</td><td align="center" valign="top" rowspan="1" colspan="1">25366.07</td><td align="center" valign="top" rowspan="1" colspan="1">21.92</td><td align="center" valign="top" rowspan="1" colspan="1">772</td><td align="center" valign="top" rowspan="1" colspan="1">0.61</td><td align="center" valign="top" rowspan="1" colspan="1">0.76</td><td align="center" valign="top" rowspan="1" colspan="1">17115.49</td><td align="center" valign="bottom" rowspan="1" colspan="1">15.83</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2016</td><td align="center" valign="top" rowspan="1" colspan="1">1,042</td><td align="center" valign="top" rowspan="1" colspan="1">0.77</td><td align="center" valign="top" rowspan="1" colspan="1">0.87</td><td align="center" valign="top" rowspan="1" colspan="1">25657.66</td><td align="center" valign="top" rowspan="1" colspan="1">20.58</td><td align="center" valign="top" rowspan="1" colspan="1">818</td><td align="center" valign="top" rowspan="1" colspan="1">0.63</td><td align="center" valign="top" rowspan="1" colspan="1">0.74</td><td align="center" valign="top" rowspan="1" colspan="1">17645.04</td><td align="center" valign="top" rowspan="1" colspan="1">15.29</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2017</td><td align="center" valign="top" rowspan="1" colspan="1">1,062</td><td align="center" valign="top" rowspan="1" colspan="1">0.77</td><td align="center" valign="top" rowspan="1" colspan="1">0.87</td><td align="center" valign="top" rowspan="1" colspan="1">25918.31</td><td align="center" valign="top" rowspan="1" colspan="1">20.70</td><td align="center" valign="top" rowspan="1" colspan="1">862</td><td align="center" valign="top" rowspan="1" colspan="1">0.65</td><td align="center" valign="top" rowspan="1" colspan="1">0.76</td><td align="center" valign="top" rowspan="1" colspan="1">19486.06</td><td align="center" valign="top" rowspan="1" colspan="1">16.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2018</td><td align="center" valign="top" rowspan="1" colspan="1">1,089</td><td align="center" valign="top" rowspan="1" colspan="1">0.79</td><td align="center" valign="top" rowspan="1" colspan="1">0.84</td><td align="center" valign="top" rowspan="1" colspan="1">26442.36</td><td align="center" valign="top" rowspan="1" colspan="1">20.31</td><td align="center" valign="top" rowspan="1" colspan="1">933</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.77</td><td align="center" valign="top" rowspan="1" colspan="1">20274.61</td><td align="center" valign="bottom" rowspan="1" colspan="1">16.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2019</td><td align="center" valign="top" rowspan="1" colspan="1">1,188</td><td align="center" valign="top" rowspan="1" colspan="1">0.85</td><td align="center" valign="top" rowspan="1" colspan="1">0.90</td><td align="center" valign="top" rowspan="1" colspan="1">27842.30</td><td align="center" valign="top" rowspan="1" colspan="1">20.21</td><td align="center" valign="top" rowspan="1" colspan="1">959</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.80</td><td align="center" valign="top" rowspan="1" colspan="1">20437.09</td><td align="center" valign="top" rowspan="1" colspan="1">15.85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2020</td><td align="center" valign="top" rowspan="1" colspan="1">1,063</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td><td align="center" valign="top" rowspan="1" colspan="1">0.76</td><td align="center" valign="top" rowspan="1" colspan="1">24571.27</td><td align="center" valign="top" rowspan="1" colspan="1">17.13</td><td align="center" valign="top" rowspan="1" colspan="1">953</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.72</td><td align="center" valign="top" rowspan="1" colspan="1">19994.58</td><td align="center" valign="top" rowspan="1" colspan="1">14.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">1,176</td><td align="center" valign="top" rowspan="1" colspan="1">0.86</td><td align="center" valign="top" rowspan="1" colspan="1">0.80</td><td align="center" valign="top" rowspan="1" colspan="1">27214.54</td><td align="center" valign="top" rowspan="1" colspan="1">18.86</td><td align="center" valign="top" rowspan="1" colspan="1">980</td><td align="center" valign="top" rowspan="1" colspan="1">0.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.69</td><td align="center" valign="top" rowspan="1" colspan="1">20585.67</td><td align="center" valign="top" rowspan="1" colspan="1">14.78</td></tr></tbody></table><table-wrap-foot><p>CMR, ASMR and age-standardized YLL rate (1/100,000). CMR, crude mortality rate; ASMR, age-standardized mortality rate; YLL, years of life lost.</p></table-wrap-foot></table-wrap><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Trends in mortality rate, age-standardized mortality rate <bold>(A)</bold>, age-standardized YLL rate and YLL <bold>(B)</bold> of skin cancer by sex in China, 2013&#x02013;2021.</p></caption><graphic xlink:href="fpubh-13-1522790-g003" position="float"/></fig></sec><sec id="sec13"><title>Regional differences in China</title><p>In general, the CMR, ASMR, and age-standardized YLL rate in urban areas were lower than that in rural areas within 2013 to 2021 (<italic>p</italic> &#x0003c;&#x0202f;0.01). CMR increased in urban and rural areas but was not statistically significant in urban areas, whereas ASMR decreased (trend chi-square value&#x0202f;=&#x0202f;111.55 and 56.13, respectively, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01). Compared with 2013, the ASMR of skin cancer in rural and urban areas decreased by 16.68 and 10.51% in 2021, respectively. Age-standardized YLL rate also decreased in 2021 compared with 2013, whereas the rates in rural and urban areas decreased by 16.99 and 8.75%, respectively (<xref rid="tab2" ref-type="table">Table 2</xref>; <xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><table-wrap position="float" id="tab2"><label>Table 2</label><caption><p>Regional differences of mortality rate, age-standardized mortality rate, and disease burden of skin cancer from 2013 to 2021.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Year</th><th align="center" valign="top" colspan="5" rowspan="1">Urban areas</th><th align="center" valign="top" colspan="5" rowspan="1">Rural areas</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Death numbers</th><th align="center" valign="top" rowspan="1" colspan="1">CMR</th><th align="center" valign="top" rowspan="1" colspan="1">ASMR</th><th align="center" valign="top" rowspan="1" colspan="1">YLL</th><th align="center" valign="top" rowspan="1" colspan="1">Age-standardized YLL rate</th><th align="center" valign="top" rowspan="1" colspan="1">Death numbers</th><th align="center" valign="top" rowspan="1" colspan="1">CMR</th><th align="center" valign="top" rowspan="1" colspan="1">ASMR</th><th align="center" valign="top" rowspan="1" colspan="1">YLL</th><th align="center" valign="top" rowspan="1" colspan="1">Age-standardized YLL rate</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">2013</td><td align="center" valign="top" rowspan="1" colspan="1">471</td><td align="center" valign="top" rowspan="1" colspan="1">0.67</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">11118.09</td><td align="center" valign="top" rowspan="1" colspan="1">15.46</td><td align="center" valign="top" rowspan="1" colspan="1">1,090</td><td align="center" valign="top" rowspan="1" colspan="1">0.69</td><td align="center" valign="top" rowspan="1" colspan="1">0.99</td><td align="center" valign="top" rowspan="1" colspan="1">26183.56</td><td align="center" valign="top" rowspan="1" colspan="1">21.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2014</td><td align="center" valign="top" rowspan="1" colspan="1">537</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">0.67</td><td align="center" valign="top" rowspan="1" colspan="1">12810.17</td><td align="center" valign="top" rowspan="1" colspan="1">15.46</td><td align="center" valign="top" rowspan="1" colspan="1">1,210</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td><td align="center" valign="top" rowspan="1" colspan="1">28758.45</td><td align="center" valign="top" rowspan="1" colspan="1">20.37</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">560</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.69</td><td align="center" valign="top" rowspan="1" colspan="1">12992.63</td><td align="center" valign="top" rowspan="1" colspan="1">15.59</td><td align="center" valign="top" rowspan="1" colspan="1">1,268</td><td align="center" valign="top" rowspan="1" colspan="1">0.73</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td><td align="center" valign="top" rowspan="1" colspan="1">29488.94</td><td align="center" valign="bottom" rowspan="1" colspan="1">21.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2016</td><td align="center" valign="top" rowspan="1" colspan="1">579</td><td align="center" valign="top" rowspan="1" colspan="1">0.65</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">13358.23</td><td align="center" valign="top" rowspan="1" colspan="1">15.12</td><td align="center" valign="top" rowspan="1" colspan="1">1,281</td><td align="center" valign="top" rowspan="1" colspan="1">0.73</td><td align="center" valign="top" rowspan="1" colspan="1">0.90</td><td align="center" valign="top" rowspan="1" colspan="1">29944.47</td><td align="center" valign="top" rowspan="1" colspan="1">19.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2017</td><td align="center" valign="top" rowspan="1" colspan="1">587</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td><td align="center" valign="top" rowspan="1" colspan="1">13787.41</td><td align="center" valign="top" rowspan="1" colspan="1">15.18</td><td align="center" valign="top" rowspan="1" colspan="1">1,337</td><td align="center" valign="top" rowspan="1" colspan="1">0.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td><td align="center" valign="top" rowspan="1" colspan="1">31616.97</td><td align="center" valign="top" rowspan="1" colspan="1">20.89</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2018</td><td align="center" valign="top" rowspan="1" colspan="1">629</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.63</td><td align="center" valign="top" rowspan="1" colspan="1">14581.23</td><td align="center" valign="top" rowspan="1" colspan="1">14.90</td><td align="center" valign="top" rowspan="1" colspan="1">1,393</td><td align="center" valign="top" rowspan="1" colspan="1">0.78</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td><td align="center" valign="top" rowspan="1" colspan="1">32135.74</td><td align="center" valign="bottom" rowspan="1" colspan="1">20.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2019</td><td align="center" valign="top" rowspan="1" colspan="1">675</td><td align="center" valign="top" rowspan="1" colspan="1">0.71</td><td align="center" valign="top" rowspan="1" colspan="1">0.65</td><td align="center" valign="top" rowspan="1" colspan="1">15276.39</td><td align="center" valign="top" rowspan="1" colspan="1">14.55</td><td align="center" valign="top" rowspan="1" colspan="1">1,472</td><td align="center" valign="top" rowspan="1" colspan="1">0.81</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td><td align="center" valign="top" rowspan="1" colspan="1">33003.00</td><td align="center" valign="top" rowspan="1" colspan="1">20.49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2020</td><td align="center" valign="top" rowspan="1" colspan="1">666</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.56</td><td align="center" valign="top" rowspan="1" colspan="1">14437.85</td><td align="center" valign="top" rowspan="1" colspan="1">12.44</td><td align="center" valign="top" rowspan="1" colspan="1">1,350</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td><td align="center" valign="top" rowspan="1" colspan="1">0.86</td><td align="center" valign="top" rowspan="1" colspan="1">30128.00</td><td align="center" valign="top" rowspan="1" colspan="1">18.17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">652</td><td align="center" valign="top" rowspan="1" colspan="1">0.71</td><td align="center" valign="top" rowspan="1" colspan="1">0.55</td><td align="center" valign="top" rowspan="1" colspan="1">14368.92</td><td align="center" valign="top" rowspan="1" colspan="1">12.84</td><td align="center" valign="top" rowspan="1" colspan="1">1,504</td><td align="center" valign="top" rowspan="1" colspan="1">0.85</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td><td align="center" valign="top" rowspan="1" colspan="1">33431.29</td><td align="center" valign="top" rowspan="1" colspan="1">19.41</td></tr></tbody></table><table-wrap-foot><p>CMR, ASMR and age-standardized YLL rate (1/100,000). CMR, crude mortality rate; ASMR, age-standardized mortality rate; YLL, years of life lost.</p></table-wrap-foot></table-wrap><fig position="float" id="fig4"><label>Figure 4</label><caption><p>Trends in mortality rate, age-standardized mortality rate <bold>(A)</bold>, age-standardized YLL rate and YLL <bold>(B)</bold> of skin cancer by region in China, 2013&#x02013;2021.</p></caption><graphic xlink:href="fpubh-13-1522790-g004" position="float"/></fig></sec></sec><sec sec-type="discussion" id="sec14"><title>Discussion</title><p>Skin cancer is a serious malignant tumor worldwide and an important public-health problem. Numerous risk factors for skin cancer exist, including long-time ultraviolet (UV) exposure, age, gender and genetic susceptibility (<xref rid="ref6" ref-type="bibr">6</xref>). The most common skin cancers are MM, SCC, and BCC. In 2019, the estimated worldwide skin cancer incidences were 3.56/100,000 for MM, 30.3/100,000 for SCC, and 48.80/100,000 for BCC, whereas the mortality were 1.63/100,000 for MM, 0.73/100,000 for SCC (<xref rid="ref1" ref-type="bibr">1</xref>). Skin cancer incidences and mortality rate vary greatly among different countries and regions. Studies have shown that the incidence rate of skin cancer was 398.12 per 100,000 in England in 2019 (<xref rid="ref12" ref-type="bibr">12</xref>) and 7.4 per 100,000 person-years in Singapore within 2003&#x02013;2006 (<xref rid="ref13" ref-type="bibr">13</xref>). Meanwhile, the overall prevalence of skin cancer was 0.17&#x02013;0.45 per 100,000 within 2004&#x02013;2015 in South Korea (<xref rid="ref14" ref-type="bibr">14</xref>). In Iran, the mortality rate of skin cancer was approximately 0.5 per 100,000 from 2006 to 2010 (<xref rid="ref15" ref-type="bibr">15</xref>). In China, mortality and YLL rate of skin cancer in 2020 was 0.72 and 12.37 per 100,000, respectively (<xref rid="ref16" ref-type="bibr">16</xref>). Compared with previous studies in China, the CMR, ASMR, and age-standardized YLL rate of skin cancers in this study increased to 0.80/100,000, 0.75/100,000, and 16.84/100,000 in 2021, respectively.</p><p>Solar UVR is classified as a carcinogen by the World Health Organization (<xref rid="ref17" ref-type="bibr">17</xref>). Studies have shown that a higher skin cancer morbidity and mortality in outdoor workers and pilots probably because they are exposed to higher levels of UV radiation in outdoor works and ionizing radiation in pilots (<xref rid="ref17" ref-type="bibr">17</xref>&#x02013;<xref rid="ref19" ref-type="bibr">19</xref>). Moreover, MM increases as the climate changes and the ozone layer thins. Studies show that ozone-layer depletion increases the amount of harmful solar UV radiation reaching the Earth, resulting in increased skin cancer incidence (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref5" ref-type="bibr">5</xref>). For every 10% decrease in ozone, MM and new non-melanoma skin cancers are estimated to increase to 4,500 MM and 300,000, respectively (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref5" ref-type="bibr">5</xref>).</p><p>Apart from UVR, demographic and sociological factors are also important factors in the increased incidence of skin cancer, such as increased overall life expectancy, sunbathing and lack of sunscreen use (<xref rid="ref20" ref-type="bibr">20</xref>). Concerns related to sun-protection attitudes and behaviors differ markedly across gender, age, income, and education groups. Women, younger, and people with high socioeconomic status have more correct sun-protection beliefs (<xref rid="ref21" ref-type="bibr">21</xref>). In our study, we found differences in skin cancer mortality according to gender, with higher rates in males than in females. This is similar to Zhang et al.&#x02019;s results, i.e., males have higher incidence and mortality rates of skin cancer than females on a global scale (<xref rid="ref1" ref-type="bibr">1</xref>). The reason may be that men usually have less sun-protection behavior and more UVR exposure. Many men have expressed using umbrella and sunscreen as feminine activities (<xref rid="ref22" ref-type="bibr">22</xref>). Additionally, males have longer daily sunlight exposure time than females from 07: 00 to 17: 00, especially from 10:00 to 14:00 (<xref rid="ref21" ref-type="bibr">21</xref>). Advanced age is an important risk factor for skin cancer, and older age is associated with a higher risk of skin cancer (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref20" ref-type="bibr">20</xref>). Perhaps older people may have higher cumulative UVR exposure. Globally, skin cancer carries a high burden, especially among the older adult population, and it increases from the age of 55&#x0202f;years (<xref rid="ref1" ref-type="bibr">1</xref>). Similar to previous studies, we found that skin cancer mortality increased with age starting at age 45&#x0202f;years and was the highest in individuals over 85&#x0202f;years old. In line with previous results (<xref rid="ref23" ref-type="bibr">23</xref>), we also found a higher skin cancer mortality in rural areas than in urban ones. The reason may be that individuals living in rural areas are exposed to UV light for a longer time while working in the field, resulting in a higher cumulative dose of UVR and thus skin cancer incidence and mortality. Moreover, compared with people living in urban areas, shade seeking and sunscreen use are less frequent in the rural counterparts (<xref rid="ref24" ref-type="bibr">24</xref>). Thus, healthy lifestyle to reduce UV radiation exposure is the key to prevent the occurrence of skin cancer. Nevertheless, many Chinese people have a large deficit in knowledge and attitude regarding UV radiation (<xref rid="ref21" ref-type="bibr">21</xref>). Only 55.2% of the participants are found to be aware that UV radiation causes skin cancer and almost 80% of participants never use sunscreen during sun exposure, especially males (<xref rid="ref21" ref-type="bibr">21</xref>). Hence, to reduce skin cancer morbidity and mortality in China, more efforts and measures should be made to improve people&#x02019;s knowledge about skin cancer prevention and UVB radiation protection, especially males and rural residents.</p><p>From 2013 to 2021, we observed skin cancer ASMR of 0.75 per 100,000 in 2020, which was lower compared to the value before the pandemic such as 2019 (&#x003c7;<sup>2</sup>&#x0202f;=&#x0202f;113.17, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.01). The reason may be that patients were reluctant to seek medical care for skin cancer during the COVID-19 pandemic. As a result, mortality generally fell according to statistics from the China death cause surveillance dataset. Similarly, the number of newly diagnosed skin cancers in England declined during the COVID-19 pandemic (<xref rid="ref25" ref-type="bibr">25</xref>).</p><p>In our study, we found that the ASMR and age-standardized YLL rate continue to decreased from 2013 to 2021. However, skin cancer deaths continue to increase, and the burden of skin cancer remains heavily and should be highly valued. This can be a consequence of UVR and the aging of the population. Strategies should be developed to reduce the incidence and mortality of skin cancer, and the focus should be on preventive measures, such as UV protection, public education, and self-exams, particularly in males, older adult, and rural residents.</p><p>However, this study had several limitations. Firstly, the available datas were limited, preventing stratification of disease burden for various types of skin cancer. Secondly, in the absence of occupation and sun protection habits data, the association between skin cancer burden and UVR exposure is speculative. Although we failed to obtain the above details from existing databases within a short time frame, we still strive to collect relevant data and analyze the disease burden for different types of skin cancer and the relationship between skin cancer and UVR exposure to optimize future prevention and control policies.</p></sec></body><back><ack><p>The authors are grateful to the Chinese center for disease control and prevention that granted access to use these data.</p></ack><fn-group><fn id="fn0001"><p>
<sup>1</sup>
<ext-link xlink:href="https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/" ext-link-type="uri">https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/</ext-link>
</p></fn></fn-group><sec sec-type="data-availability" id="sec15"><title>Data availability statement</title><p>Publicly available datasets were analyzed in this study. This data can be found here: Skin cancer mortality data in our study were obtained from the China death cause surveillance dataset for the period of 2013&#x02013;2021 (<ext-link xlink:href="https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/" ext-link-type="uri">https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/</ext-link>). They were compiled by the National Health Commission Statistics Information Center and the China Center for Disease Control and Prevention Chronic Non-Communicable Diseases Prevention and Control Center.</p></sec><sec sec-type="ethics-statement" id="sec16"><title>Ethics statement</title><p>Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants&#x02019; legal guardians/next of kin in accordance with the national legislation and the institutional requirements.</p></sec><sec sec-type="author-contributions" id="sec17"><title>Author contributions</title><p>JL: Data curation, Methodology, Resources, Writing &#x02013; original draft. JZ: Formal analysis, Methodology, Writing &#x02013; original draft. YY: Conceptualization, Visualization, Writing &#x02013; review &#x00026; editing. BH: Conceptualization, Project administration, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="sec19"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="sec20"><title>Generative AI statement</title><p>The author(s) declare that no Gen AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="sec21"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Aofei</surname><given-names>J</given-names></name><name><surname>Zhi</surname><given-names>H</given-names></name><name><surname>Xiaoping</surname><given-names>S</given-names></name><name><surname>Xian</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the global burden of disease study 2019</article-title>. <source>Cancer Med</source>. (<year>2021</year>) <volume>10</volume>:<fpage>4905</fpage>&#x02013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cam4.4046</pub-id>, PMID: <pub-id pub-id-type="pmid">34105887</pub-id>
</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazhanichamy</surname><given-names>K</given-names></name><name><surname>Hui Bing</surname><given-names>T</given-names></name><name><surname>Jiun Yit</surname><given-names>P</given-names></name><name><surname>Suat Hoon</surname><given-names>T</given-names></name><name><surname>Thirumaran</surname><given-names>T</given-names></name></person-group>. <article-title>Overexpression of CDC42SE1 in A431 cells reduced cell proliferation by inhibiting the Akt pathway</article-title>. <source>Cells</source>. (<year>2019</year>) <volume>8</volume>:<fpage>8</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells8020117</pub-id>, PMID: <pub-id pub-id-type="pmid">30717410</pub-id>
</mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lixin</surname><given-names>L</given-names></name><name><surname>Meijie</surname><given-names>Q</given-names></name><name><surname>Yanru</surname><given-names>L</given-names></name><name><surname>Yujie</surname><given-names>L</given-names></name><name><surname>Xing</surname><given-names>L</given-names></name><name><surname>Zhoufeng</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Staging of skin Cancer based on hyperspectral microscopic imaging and machine learning</article-title>. <source>Biosensors (Basel)</source>. (<year>2022</year>) <volume>12</volume>:<fpage>12</fpage>. doi: <pub-id pub-id-type="doi">10.3390/bios12100790</pub-id>, PMID: <pub-id pub-id-type="pmid">36290928</pub-id>
</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabin</surname><given-names>N</given-names></name><name><surname>Sai</surname><given-names>HS</given-names></name><name><surname>Sami</surname><given-names>A-DM</given-names></name><name><surname>Devi</surname><given-names>BR</given-names></name><name><surname>David</surname><given-names>T</given-names></name><name><surname>Jayachandra</surname><given-names>BR</given-names></name><etal/></person-group>. <article-title>Transdermal delivery of chemotherapeutics: strategies, requirements, and opportunities</article-title>. <source>Pharmaceutics</source>. (<year>2021</year>) <volume>13</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pharmaceutics13070960</pub-id>, PMID: <pub-id pub-id-type="pmid">34206728</pub-id>
</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll1">WHO Radiation</collab></person-group> (<year>2017</year>). Ultraviolet (UV) Radiation and skin Cancer. Available at: <ext-link xlink:href="https://www.who.int/news-room/q-a-detail/ultraviolet-(uv)-radiation-and-skin-cancer" ext-link-type="uri">https://www.who.int/news-room/q-a-detail/ultraviolet-(uv)-radiation-and-skin-cancer</ext-link> (Accessed October 12, 2024).</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoe</surname><given-names>A</given-names></name><name><surname>Aimilios</surname><given-names>L</given-names></name><name><surname>Elena</surname><given-names>S</given-names></name><name><surname>Elizabeth</surname><given-names>L</given-names></name><name><surname>Demetrios</surname><given-names>I</given-names></name></person-group>. <article-title>Epidemiological trends in skin cancer</article-title>. <source>Dermatol Pract Concept</source>. (<year>2017</year>) <volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.5826/dpc.0702a01</pub-id>, PMID: <pub-id pub-id-type="pmid">28515985</pub-id>
</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingfeng</surname><given-names>H</given-names></name><name><surname>Rongshou</surname><given-names>Z</given-names></name><name><surname>Hongmei</surname><given-names>Z</given-names></name><name><surname>Shaoming</surname><given-names>W</given-names></name><name><surname>Kexin</surname><given-names>S</given-names></name><name><surname>Ru</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Cancer incidence and mortality in China, 2022</article-title>. <source>J Natl Cancer Cent</source>. (<year>2024</year>) <volume>4</volume>:<fpage>47</fpage>&#x02013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jncc.2024.01.006</pub-id>, PMID: <pub-id pub-id-type="pmid">39036382</pub-id>
</mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricard</surname><given-names>G-M</given-names></name><name><surname>Ferr&#x000e1;n</surname><given-names>C-L</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>L-BN</given-names></name><name><surname>Elena</surname><given-names>&#x000c1;-M</given-names></name><name><surname>Consuelo</surname><given-names>M-G</given-names></name></person-group>. <article-title>The burden of premature mortality in Spain using standard expected years of life lost: a population-based study</article-title>. <source>BMC Public Health</source>. (<year>2011</year>) <volume>11</volume>:<fpage>787</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2458-11-787</pub-id>, PMID: <pub-id pub-id-type="pmid">21989453</pub-id>
</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Lv</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Temperature change between neighboring days contributes to years of life lost per death from respiratory disease: a multicounty analysis in Central China</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2022</year>) <volume>19</volume>:<fpage>19</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph19105871</pub-id>, PMID: <pub-id pub-id-type="pmid">35627408</pub-id>
</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Lijun</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yun</surname><given-names>L</given-names></name><name><surname>Maigeng</surname><given-names>Z</given-names></name></person-group>. <article-title>Burden of melanoma in China, 1990-2017: findings from the 2017 global burden of disease study</article-title>. <source>Int J Cancer</source>. (<year>2019</year>) <volume>147</volume>:<fpage>692</fpage>&#x02013;<lpage>701</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ijc.32764</pub-id>, PMID: <pub-id pub-id-type="pmid">31671209</pub-id>
</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll2">Department of Data and Analytics</collab></person-group> (<year>2020</year>). D.O.D., analytics and delivery for impact, WHO, Geneva, WHO methods and data sources for global burden of disease estimates 2000&#x02013;2019. Available at: <ext-link xlink:href="https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf?sfvrsn=31b25009_7" ext-link-type="uri">https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf?sfvrsn=31b25009_7</ext-link> (Accessed January 22, 2025).</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birgitta</surname><given-names>VB</given-names></name><name><surname>Sally</surname><given-names>V</given-names></name><name><surname>Charlotte</surname><given-names>E</given-names></name><name><surname>Ruth</surname><given-names>B</given-names></name><name><surname>Paul</surname><given-names>C</given-names></name><name><surname>Sonia</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>'Get data Out' skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England</article-title>. <source>Br J Dermatol</source>. (<year>2023</year>) <volume>188</volume>:<fpage>777</fpage>&#x02013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bjd/ljad033</pub-id>, PMID: <pub-id pub-id-type="pmid">36814132</pub-id>
</mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judy</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>K</given-names></name><name><surname>Wong Chia</surname><given-names>S</given-names></name><name><surname>Tai Bee</surname><given-names>C</given-names></name></person-group>. <article-title>Skin cancer trends among Asians living in Singapore from 1968 to 2006</article-title>. <source>J Am Acad Dermatol</source>. (<year>2009</year>) <volume>61</volume>:<fpage>426</fpage>&#x02013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaad.2009.03.031</pub-id>, PMID: <pub-id pub-id-type="pmid">19628302</pub-id>
</mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sul Hee</surname><given-names>L</given-names></name><name><surname>Jun-Soo</surname><given-names>R</given-names></name><name><surname>Kee Yang</surname><given-names>C</given-names></name><name><surname>Sang Hoon</surname><given-names>L</given-names></name><name><surname>Young Lip</surname><given-names>P</given-names></name><name><surname>Jung Eun</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Association between skin Cancer and systemic and ocular comorbidities in South Korea</article-title>. <source>J Clin Med</source>. (<year>2021</year>) <volume>10</volume>:<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm10112451</pub-id>, PMID: <pub-id pub-id-type="pmid">34205919</pub-id>
</mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reza</surname><given-names>P</given-names></name><name><surname>Shahin</surname><given-names>S</given-names></name><name><surname>Hamid</surname><given-names>S</given-names></name></person-group>. <article-title>Epidemiology and trend in skin cancer mortality in Iran</article-title>. <source>J Res Med Sci</source>. (<year>2016</year>) <volume>20</volume>:<fpage>921</fpage>&#x02013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.4103/1735-1995.170637</pub-id>, PMID: <pub-id pub-id-type="pmid">26759582</pub-id>
</mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jinlei</surname><given-names>Q</given-names></name><name><surname>Menglong</surname><given-names>L</given-names></name><name><surname>Lijun</surname><given-names>W</given-names></name><name><surname>Yifei</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data</article-title>. <source>Lancet Public Health</source>. (<year>2023</year>) <volume>8</volume>:<fpage>e943</fpage>&#x02013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2468-2667(23)00211-6</pub-id>, PMID: <pub-id pub-id-type="pmid">38000889</pub-id>
</mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>P</given-names></name><name><surname>Natalie</surname><given-names>CS</given-names></name><name><surname>Kai</surname><given-names>NL-R</given-names></name><name><surname>Maria</surname><given-names>N</given-names></name><name><surname>Subas</surname><given-names>S-B</given-names></name><name><surname>Mary</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000-2019: a systematic analysis from the WHO/ILO joint estimates of the work-related burden of disease and injury</article-title>. <source>Environ Int</source>. (<year>2023</year>) <volume>181</volume>:<fpage>108226</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.envint.2023.108226</pub-id>, PMID: <pub-id pub-id-type="pmid">37945424</pub-id>
</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeyong</surname><given-names>S</given-names></name><name><surname>Kee Yang</surname><given-names>C</given-names></name><name><surname>Eun-Cheol</surname><given-names>P</given-names></name><name><surname>Kyoung Ae</surname><given-names>N</given-names></name><name><surname>Jin-Ha</surname><given-names>Y</given-names></name></person-group>. <article-title>Occupational differences in standardized mortality ratios for non-melanotic skin cancer and melanoma in exposed areas among individuals with Fitzpatrick skin types III and IV</article-title>. <source>J Occup Health</source>. (<year>2019</year>) <volume>61</volume>:<fpage>235</fpage>&#x02013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1002/1348-9585.12040</pub-id>, PMID: <pub-id pub-id-type="pmid">30761684</pub-id>
</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>S</given-names></name><name><surname>Christopher</surname><given-names>J</given-names></name><name><surname>Jeffrey</surname><given-names>B</given-names></name></person-group>. <article-title>Predictors of skin cancer in commercial airline pilots</article-title>. <source>Occup Med (Lond)</source>. (<year>2009</year>) <volume>59</volume>:<fpage>434</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1093/occmed/kqp058</pub-id>, PMID: <pub-id pub-id-type="pmid">19465434</pub-id>
</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suvi-P&#x000e4;ivikki</surname><given-names>S</given-names></name><name><surname>Jari</surname><given-names>J</given-names></name><name><surname>Sirkka</surname><given-names>K-K</given-names></name><name><surname>Laura</surname><given-names>H</given-names></name></person-group>. <article-title>Skin cancers and their risk factors in older persons: a population-based study</article-title>. <source>BMC Geriatr</source>. (<year>2022</year>) <volume>22</volume>:<fpage>269</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-022-02964-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35361154</pub-id>
</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuxian</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Chunxue</surname><given-names>Y</given-names></name><name><surname>Fei</surname><given-names>L</given-names></name><name><surname>Jing</surname><given-names>F</given-names></name><name><surname>Linggao</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Demographic differences in sun protection beliefs and behavior: a community-based study in Shanghai, China</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2015</year>) <volume>12</volume>:<fpage>3232</fpage>&#x02013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph120303232</pub-id>, PMID: <pub-id pub-id-type="pmid">25794187</pub-id>
</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname><given-names>M</given-names></name><name><surname>Brian</surname><given-names>M</given-names></name><name><surname>Ghazal</surname><given-names>G</given-names></name><name><surname>James</surname><given-names>N</given-names></name><name><surname>Vinayak</surname><given-names>K</given-names></name><name><surname>Linda</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Skin Cancer knowledge, attitudes, and practices among Chinese population: a narrative review</article-title>. <source>Dermatol Res Pract</source>. (<year>2018</year>) <volume>2018</volume>:<fpage>1965674</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2018/1965674</pub-id>, PMID: <pub-id pub-id-type="pmid">29973951</pub-id>
</mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michael</surname><given-names>C</given-names></name><name><surname>Mark</surname><given-names>S</given-names></name><name><surname>Joanne</surname><given-names>A</given-names></name><name><surname>Peter</surname><given-names>B</given-names></name><name><surname>Ian</surname><given-names>R</given-names></name></person-group>. <article-title>Urban-rural differences in survival from cutaneous melanoma in Queensland</article-title>. <source>Aust N Z J Public Health</source>. (<year>2006</year>) <volume>30</volume>:<fpage>71</fpage>&#x02013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1467-842x.2006.tb00089.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16509022</pub-id>
</mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elizabeth</surname><given-names>S</given-names></name><name><surname>Bridget</surname><given-names>G</given-names></name><name><surname>Benjamin</surname><given-names>H</given-names></name><name><surname>Kenneth</surname><given-names>T</given-names></name><name><surname>Kelsey</surname><given-names>Z</given-names></name><name><surname>Angela</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Differences in reported sun protection practices, skin cancer knowledge, and perceived risk for skin cancer between rural and urban high school students</article-title>. <source>Cancer Causes Control</source>. (<year>2019</year>) <volume>30</volume>:<fpage>1251</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10552-019-01228-5</pub-id>, PMID: <pub-id pub-id-type="pmid">31522321</pub-id>
</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>TW</given-names></name><name><surname>Alrawi</surname><given-names>M</given-names></name><name><surname>Lovat</surname><given-names>P</given-names></name></person-group>. <article-title>Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic</article-title>. <source>Clin Exp Dermatol</source>. (<year>2020</year>) <volume>46</volume>:<fpage>145</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ced.14411</pub-id>, PMID: <pub-id pub-id-type="pmid">32754962</pub-id>
</mixed-citation></ref></ref-list></back></article>